Arrowhead Pharmaceuticals Inc. (ARWR)
NASDAQ · Healthcare
Arrowhead Pharmaceuticals Inc. Total Liabilities 2011–2025
Arrowhead Pharmaceuticals Inc. annual total liabilities history from 2011 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Arrowhead Pharmaceuticals Inc. total liabilities as of September 30, 2025: 919.2M, a 3.68% decrease year-over-year.
- Arrowhead Pharmaceuticals Inc. total liabilities for 2025 were 919.2M, a 3.68% decrease from 2024.
- Arrowhead Pharmaceuticals Inc. total liabilities for 2024 were 954.4M, a 93.11% increase from 2023.
- Arrowhead Pharmaceuticals Inc. total liabilities for 2023 were 494.2M, a 68.43% increase from 2022.
- Arrowhead Pharmaceuticals Inc. total liabilities for 2022 were 293.4M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Arrowhead Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $919 |
| 2024 | $954 |
| 2023 | $494 |
| 2022 | $293 |
| 2021 | $301 |
| 2020 | $61 |
| 2019 | $105 |
| 2018 | $16 |
| 2017 | $23 |
| 2016 | $33 |
| 2015 | $22 |
| 2014 | $16 |
| 2013 | $10 |
| 2012 | $7 |
| 2011 | $3 |
Arrowhead Pharmaceuticals Inc. Total Liabilities — FAQ
Arrowhead Pharmaceuticals Inc. (ARWR) total liabilities over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARWR's total liabilities history?
The chart and table above show Arrowhead Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.